Why the study?
Suboptimal utilization and under-dosing of ACE inhibitors in chronic heart failure are linked to worse outcomes, prompting an assessment of their utilization and dose optimization at AUTH.
Despite high prescription rates of ACE inhibitors in patients with HFrEF, optimal target dosing remains poorly achieved, highlighting a gap in guideline-directed medical therapy implementation.
Answers are grounded in this paper and cite their sources.
Indicates ongoing GDMT implementation gaps in HFrEF; leaves open whether targeted interventions can improve ACEI dose optimization.
Background and Aims: Angiotensin-converting enzyme inhibitors (ACEIs) are well established in reducing morbidity and mortality among patients with chronic heart failure (CHF). Evidence has consistently supported the use of high-dose ACEI therapy, which is recommended to optimize clinical outcomes and enhance patients' quality of life. Suboptimal utilization and under-dosing of these agents are associated with increased rates of hospitalization, worsening symptoms of heart failure, and overall, poor prognoses. We assessed the utilization and dose optimization of ACEIs in heart failure patients at the Adult University Teaching Hospital (AUTH). Methods: This was a cross-sectional study conducted among adult patients with with a confirmed diagnosis of CHF and an ejection fraction of < 40%. A checklist was used to collect data, which was subsequently analysed using STATA version 15.1. Multivariable logistic regression was used to determine associated factors. Hypertension was the most common comorbidity, affecting 183 (62.5%) participants while the majority, 176 (60.4%) of the individuals had less than two comorbidities. Conclusion: Although the majority of patients were receiving ACEIs, only a small proportion of these were using optimal dosages. Therefore, a multidisciplinary team approach that includes clinical pharmacists in the medication review and patient monitoring processes would achieve definite outcomes in patients with HF.
No takes yet. Share an insight, caveat, or question.
Kampamba et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: